Indoco Remedies Q2 Review — Dolat Capital Hikes Target Price Maintaining ‘Sell’, Sees 15% Downside

Indoco has completed remediation at Goa Plant-II and invited the U.S. FDA for inspection, which could be a key trigger for re-rating. Indoco has partnered with UK-based Clarity Pharma to launch 15 products, with 4–5 already introduced, boosting its UK footprint.